Promising new option for first line of attack in lymphoma
Wednesday, February 26, 2014 - 06:33
in Health & Medicine
Follicular lymphoma is a type of non-Hodgkin’s lymphoma -– a blood cancer -- that usually develops slowly. The majority of patients are diagnosed when their disease is at an advanced stage. Recent improvements in treatment have included the use of antibodies to specifically target the tumor cells and to stimulate the patient’s own immune system to attack their tumor. The use of such antibodies has improved treatment response, but unfortunately most patients still relapse Radioimmunotherapy -- where a radioactive substance is attached to the antibody -- has been shown to be successful in treating patients who had previously relapsed.